Y

Abstract

Reporting of suspected adverse reactions to drugs in the UK; Spontaneous reporting scheme (reporting primarily by patients in contrast to active drug safety monitoring, prescription-event monitoring by health professionals) established 1964 and operated by the MHRA in UK; the system is completely voluntary whereby physicians but also dentists, coronors and patients are encouraged to report (other countries accept only reporting of side effects by health care professionals); incomplete information provided often limit it’s use; other reporting systems are e.g., the Canadian Adverse Reaction Monitoring Program (CADRMP) or the Adverse Event Reporting System (AERS) of the U.S.; see also Black Triangle, case-control study, epidemiology, EudraVigilance, MedWatch, pharmacovigilance, who collaborating centre for international drug monitoring.